About Opamtistomig (LBL-024). Opamtistomig (LBL-024) is a potential first-in-class bispecific antibody that simultaneously targets PD-L1 and the co-stimulatory receptor 4-1BB.
MASTERWORKS 024, LLC... Masterworks 024, LLC ... MASTERWORKS 024, LLC ... Masterworks 024 LLC published this content on January 12, 2026, and is solely responsible for the information contained herein.
9887.HK) today announced that the first patient has been successfully dosed in a Phase Ⅰb/Ⅱ clinical study evaluating Opamtistomig (LBL-024), a PD-L1/4-1BB bispecific antibody, for the platinum-resistant ovarian cancer ... About Opamtistomig (LBL-024).
The Chinese company said its Power Max 1800 SE has a rated power of 1.8 kW and a surge power of 2.4 kW ...The Power Max 1800 SE packs a lithium iron phosphate (LiFePO4) cell with a capacity of 1,024 Wh ... ....
Monad price has retraced after a strong rally, with a recent public dispute over its valuation weakening sentiment. Monad is trading around $0.0242, down roughly 19% in the past day as traders react to a sharp cooldown and the ongoing ....